Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
3000
Trial Sponsor
Clinical Trial Start Date
March 23, 2022
0Primary Completion Date
June 30, 2024
0Study Completion Date
June 30, 2024
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Prevention0
Intervention Type
Behavioral0
Intervention Name
Mobile health0
Usual care0
Interventional Trial Phase
Not Applicable0
Participating Facility
Official Name
Addressing Disparity in Diabetes Prevention Through Digital Health Supported PRe-diabetes Intervention, Management and Evaluation (PRIME) Program Based in Malaysian Community Pharmacies0
Last Updated
June 16, 2022
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Double0
Masked Party
Outcomes Assessor0
Participant0
Study summary
Currently, an estimated 3.9 million Malaysians continue to live with diabetes with many more who live with prediabetes. Diabetes was the one of the leading causes of death in the Malaysia and the leading cause for kidney failure, lower-limb amputations, and adult-onset blindness. Heart disease and stroke are two to four times more likely for individuals with diabetes. The use of mHealth or mobile health application can reduce blood sugar among individuals with prediabetes but also prevent a later occurrence of diabetes. In this study, the investigators aim to develop and evaluate the effectiveness of a digital health supported pre-diabetes management program based in an urban community pharmacy setting
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
